Navigation Links
FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients
Date:2/27/2008

Advanced technology capable of detecting minute numbers of circulating cancer cells in a blood sample; the CellSearch(TM) test can help guide patient care decisions

RARITAN, N.J., Feb. 27 /PRNewswire/ -- Veridex, LLC today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch(TM) System to be used as an aid in the monitoring of metastatic prostate cancer (MPC) patients. The CellSearch(TM) System currently is cleared for monitoring metastatic breast and metastatic colorectal cancer patients.

The CellSearch(TM) System identifies and counts circulating tumor cells (CTCs) in a blood sample to predict progression-free survival and overall survival in patients with metastatic breast, colorectal or prostate cancer, and can do so earlier than the current standard of care. The results of serial testing for CTCs with the CellSearch(TM) System provide additional information to the oncologist and does so earlier than other currently approved diagnostic modalities, thereby allowing the oncologist to make more-informed patient care decisions.

According to the American Cancer Society, prostate cancer claims approximately 27,000 lives each year, the vast majority of which are a result of recurrent metastatic disease. Metastatic prostate cancer occurs when tumor cells spread to other locations in the body and grow. Currently, oncologists often have to wait several months before they can determine if a specific treatment is beneficial to the patient. The CellSearch(TM) System helps physicians to predict disease progression and patient survival any time during therapy.

"I am extremely pleased that we now can offer this test to patients with metastatic prostate cancer," said Dr. Louis Fink of the Nevada Cancer Institute in Las Vegas, Nevada. "We have been evaluating the clinical utility of the CellSearch(TM) System in patients with metastatic prostate cancer since January 2007. Our find
'/>"/>

SOURCE Veridex, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Global Gene Map Clears New Milestone
2. FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
3. American Medical Association Clears Path for Adenoviral Conjunctivitis - Pink Eye - Detector
4. Congress Clears the Way for National CPR and AED Awareness Week
5. Circulating fats kill transplanted pancreas cells, study shows
6. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
7. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
8. Study details regulation of vital tumor suppressor gene p53
9. Human C-reactive protein regulates myeloma tumor cell growth and survival
10. Customized virus kills brain tumor stem cells that drive lethal cancer
11. Study suggests brain tumors need treatment with multiple targeted drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... New York, NY (PRWEB) September 21, 2014 ... companies that help businesses and manufacturers perform tests on ... materials. In an increasingly regulated society, pressure on operators ... is higher than ever. A greater number of government ... testing of manufacturers' goods prior to sale. Although revenue ...
(Date:9/21/2014)... Over the past five years, the patent ... market, thereby cutting into revenue growth for the ... from Industry Canada, the loss of patent protection for ... billion in 2010 and 2012, respectively. “In response to ... hampered revenue growth, many pharmaceutical manufacturers have streamlined their ...
(Date:9/21/2014)... 22, 2014 The asthma market ... as it has become saturated with relatively efficacious ... corticosteroids (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), ... increasing generic competition. However, the launch of seven ... ICS/LABA therapies delivered by the next-generation inhalers will ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 The ... BHWG) will host a statewide symposium ( tinyurl.com/ILBHC14 ... Veterans, and their Families. Sponsored by the VNA ... Lottery Cash Grant, and Health & Disability Advocates, ... at the Hilton Hotel in Springfield, IL. ...
(Date:9/21/2014)... September 21, 2014 Hundreds of ... forward in Pennsylvania’s Philadelphia Court of Common Pleas, ... the proceeding’s next monthly meeting has been scheduled ... 100300296) , “Our Firm is representing a number ... this litigation. We are pleased with its continued ...
Breaking Medicine News(10 mins):Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 2Health News:Enhancing Clinical Competence to Serve Veterans, a Statewide Symposium 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4
... a breakthrough discovery, American researchers have found some of the ... the womb. There have always been theories that unborn babies ... is read to or played music while still in the ... has been questionable in the past because there has been ...
... and Emcure Pharmaceuticals Ltd, a Pune-based company have jointly ... of hypertension. Announcing this at a press conference here ... Satish Mehta said the chirally pure S-Amlodipine, a product ... for the patients suffering from hypertension. ,Stating ...
... of almonds a day may improve your cholesterol. Previous ... of coronary heart disease by lowering cholesterol.// However, eating ... not recommended for people who need to restrict calories. ... almonds can reduce heart disease risk by lowering cholesterol. ...
... alone may be enough to treat some patients with ... studied 60 patients between 1985 and 1999.// Typical treatment ... surgery is not an option. ,In this study, ... for surgery to remove it. A combination radiation therapy ...
... helping your blood clot properly.It is so important that all ... The vitamin is found most commonly in leafy green ... do not have bacteria established, they need supplemental vitamin K. ... and 90 micrograms for women was set. Because no ...
... who will get Alzheimer's disease from healthy older people. Alzheimer's ... we can expect an increase in the number of cases ... seem to work best if they start early. This means ... University of Toronto have been analysing investigations on 1,000 Alzheimer's ...
Cached Medicine News:Health News:Almonds Improve Cholesterol 2
(Date:9/19/2014)... Research and Markets ... of the "Global Gynecological Devices Market ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... wide categories based on their operations. These ... different gynecological conditions that affect the female ...
(Date:9/19/2014)... 19, 2014  4WEB Medical announces the formal launch ... ankle osteotomy implants on the market today at ... meeting in Chicago .  The Osteotomy ... osteotomy needs with 74 size options included in one ... of only 15 to 18 implant sizes, which limited ...
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica US ... leading online community to help oncologists and other clinicians ... regarding the use of targeted therapies and immunotherapies, discusses ... and treatment.  Every September, Blood ... to raise awareness about blood cancers—helping to increase survival ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
Lyphochek Whole Blood Metals Control contains the major heavy metals of toxicological and environmental importance for whole blood analysis....
Lyphochek Urine Metals Control incorporates two levels of critical trace elements, heavy metals and organic metabolites, and is ideal for environmental and industrial testing....
Liquichek Urinalysis Control is specifically designed for urine dipstick and microscopic testing. This control provides clear, visual positive and negative results, including hCG (pregnancy) and micr...
qUAntify Control is designed to monitor the performance of urine dipstick testing. The control is available in 12 mL ready-to-use dropper bottles....
Medicine Products: